{"id":"W2119607431","doi":"10.1200/jco.2010.34.1578","title":"Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":338,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Temsirolimus; PTEN; Medicine; Internal medicine; Endometrial cancer; Chemotherapy; Progressive disease; Oncology; PI3K/AKT/mTOR pathway; Tensin; Cancer; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Cancer research; Biology; Signal transduction; Discovery and development of mTOR inhibitors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001371308,0.0009939683,0.001228596,0.0003252615,0.0003310598,0.0004977432,0.0006728689,0.001218237,0.002906369],"category_scores_gemma":[0.001022867,0.0003522426,0.0007286151,0.000305843,0.0005419682,0.0004272682,0.0002355765,0.001871954,0.0004414456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006623741,"about_ca_system_score_gemma":0.001763014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001277398,"about_ca_topic_score_gemma":0.003180672,"domain_scores_codex":[0.9997374,0.0001562942,0.00001254013,0.00003872007,0.00002252662,0.00003248743],"domain_scores_gemma":[0.9995203,0.0001028039,0.00009459342,0.00003220684,0.00003483895,0.000215252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7576222,0.02531374,0.008035879,0.001479758,0.001529596,0.0003661196,0.0003474141,0.002800599,0.02885297,0.0006157665,0.008768311,0.1642677],"study_design_scores_gemma":[0.8321114,0.1525104,0.008659377,0.00005526007,0.000278824,0.0002400058,0.00003753503,0.001037644,0.001398149,0.0001787195,0.003476993,0.00001570775],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9834599,0.00677297,0.0005451052,0.001492769,0.0001789709,0.003583046,0.001061399,0.00008067914,0.002825021],"genre_scores_gemma":[0.9808894,0.003835043,0.002526757,0.00202838,0.0002293421,0.005016252,0.002390434,0.00001767205,0.003066769],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002906369,"threshold_uncertainty_score":0.009722829,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3924537037993933,"score_gpt":0.5550164775171609,"score_spread":0.1625627737177676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}